Mail

It's us vs. cancer This "new" strategy, in which cancer researchers beat the disease by collaborating in massive projects,1 is bound to fail. Why? Because enforced cooperation for the sake of obtaining research grants is counterproductive to a physiologic matching of research interests, including a viable chemistry between participating scientists. The European grant programs for coo

Written byThe Scientist
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

This "new" strategy, in which cancer researchers beat the disease by collaborating in massive projects,1 is bound to fail. Why? Because enforced cooperation for the sake of obtaining research grants is counterproductive to a physiologic matching of research interests, including a viable chemistry between participating scientists. The European grant programs for cooperative research, based on the same intentions as described by the authors, have not only turned out to be bureaucratic nightmares but also fostered wrong motivations for collaborations. There are already numerous cooperative cancer programs in the US, Europe and Asia which take advantage of the great diversity of expertise, focus and motivation without major governmental interference.

Rainer Zahlten
University of Frankfurt am Main Medical School
Frankfurt, Germany
rzahlten@t-online.de

Our small lab has received nearly 30 years of continuous National Cancer Institute support that has allowed the training of both graduate and undergraduate students in molecular biology focused on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems